Andrew Sides

Andrew Sides is a seasoned professional in the pharmaceutical and biopharmaceutical industries, currently serving as Senior Director and Head of Global Portfolio Analytics and Forecasting at Alexion Pharmaceuticals, Inc. since July 2022. In this role, Andrew leads a global team focused on developing forecasting and reporting capabilities to support pipeline opportunities and enterprise decision-making. Prior to this, Andrew held positions at Two Labs, where responsibilities included serving as Principal and Engagement Manager, delivering consulting services for product launch strategy and management. Experience also encompasses roles at Sanofi Genzyme as a Systems Engineer, where Andrew optimized manufacturing operations, and Pfizer as a Process Engineer, executing technical projects for clinical manufacturing. Educational qualifications include a Master of Business Administration from Boston College and a Bachelor of Science in Biomedical Engineering from Worcester Polytechnic Institute.